SVA [SINOVAC BIOTECH] 6-K: Sinovac and Butantan Join Efforts to Advance the

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2020-06-11
Original SEC Filing: Click here


Webplus: SVA/20200611/6-K/2_EX-99.1/000.htm SEC Original: tm2022386d1_ex99-1.htm
Sinovac and Butantan Join Efforts to Advance the Clinical Development of An Inactivated Vaccine for COVID-19 to Phase III Beijing (China), Sao Paulo, (Brazil), June 11th, 2020 Science Sinovac has made significant progress in the development of CoronaVac. Promising preclinical results regarding CoronaVac were recently published in the peer-reviewed academic journal Through this collaboration, Instituto Butantan will sponsor Phase III




Webplus: SVA/20200611/6-K/1/000.htm SEC Original: tm2022386d1_6k.htm



Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2020-06-11CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200

Home Page Forums

By | 2020-10-01T15:38:23+00:00 June 11th, 2020|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar